Tonix Pharmaceuticals Holding Corp. (TNXP)
| Previous Close | 2.2100 |
| Open | 2.3000 |
| Bid | 2.8300 x 3200 |
| Ask | 2.8400 x 900 |
| Day's Range | 2.0800 - 2.5900 |
| 52 Week Range | 1.9100 - 45.4400 |
| Volume | |
| Avg. Volume | 1,854,173 |
| Market Cap | 1.26B |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2770 |
| Earnings Date | Mar 14, 2022 - Mar 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.70 |
- Motley Fool
Why Tonix Pharmaceuticals Continued to Plummet Today
Tonix Pharmaceuticals (NASDAQ: TNXP) is a biotech stock that's having an absolutely awful week. On Wednesday, the company's shares fell sharply for a third straight day, closing more than 13% lower. Investors are clearly shaken by Tonix's current attempt at financial engineering.
- GlobeNewswire
Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2
Tonix Exercises Option to License Antiviral Technology PlatformNEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research university, focused on identifying and testing broad-spectrum antiviral drugs against future variants of SARS-CoV-2 and o
- Motley Fool
Why Tonix Pharmaceuticals Stock Is Crashing Again Today
Shares of Tonix Pharmaceuticals Holding (NASDAQ: TNXP) were crashing 22.7% as of 10:54 a.m. ET on Tuesday. This stock split took effect today. Reverse stock splits aren't a sign that things are going well for a company.
